Femoral Implant Articles & Analysis
8 news found
The VenoValve® is bioprosthetic valve that is surgically implanted into the femoral vein as a potential treatment for deep venous CVI. ...
The Company’s lead product, the VenoValve®, is a first-in-class implant being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). ...
” The VenoValve® is bioprosthetic valve that is surgically implanted into the femoral vein as a potential treatment for deep venous CVI. ...
The Company’s lead product, the VenoValve®, is a first-in-class implant being developed for the treatment of deep venous Chronic Venous Insufficiency (CVI). ...
In early 2022, the Company announced that it had received ISO 13485 certification for its Irvine facility covering the design, development, and manufacture of tissue based implantable medical devices. Progress has continued on a second product for the treatment of venous disease which the Company expects to announce in mid-2022. ...
” The VenoValve is a first-in-class surgically implanted currently undergoing the SAVVE U.S. pivotal trial for safety and effectiveness as a treatment of deep venous Chronic Venous Insufficiency (CVI). ...
Patients with replacement implants achieved superior results the second time; 70% of patients used one implant and 20% received a replacement implant. ...
Scope 1.1 This specification covers the material requirements for high-purity, dense aluminum oxide for load-bearing surgical implant applications. 1.2 This specification does not cover finished parts (for example, femoral heads, acetabular inserts, dental implants and the ...